AzTrials
AzTrials

Mobility LimitationNCT02947230

Evaluating the Impact of the McMaster Optimal Aging Portal on Physical Mobility Outcomes

A study testing Tailored Knowledge Translation in people with Mobility Limitation, run by McMaster University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The McMaster Optimal Aging Portal (the Portal) was launched in 2014 to increase public access to trustworthy health information. The Portal helps readers to access evidence-based resources; identify trustworthy messages; and understand scientific findings. Read more about this study

Who is it for?
Ages 40 years and olderHealthy volunteers can take part
Conditions the study is for
Mobility Limitation
What is being tested?
Tailored Knowledge Translation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
535 participants
Where
1 siteCanada
Study dates
7 Mar 2017to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • English-speaking

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

Canada1 site

  • McMaster University

    Hamilton, Ontario, L8P0A1

Other trials in Canada

About this study

Official title: Evaluating the Impact of the McMaster Optimal Aging Portal on Knowledge, Behavioural Intentions and Health Behaviours Related to Physical Mobility

The McMaster Optimal Aging Portal (the Portal) was launched in 2014 to increase public access to trustworthy health information. The Portal helps readers to access evidence-based resources; identify trustworthy messages; and understand scientific findings. Now the investigators want to know whether using the Portal changes what people know and do to stay healthy and mobile.

This project will help us to:

  1. Understand how middle aged and older adults (age 40+) use the Portal to obtain information about maintaining and improving mobility
  2. Evaluate whether use of the Portal results in a change in knowledge about maintaining and improving mobility, or change in lifestyle behaviours that may help maintain or improve mobility with age.
Read the detailed description

Physically active lifestyles are important for health aging, but most Canadians do not meet published physical activity guidelines. This may be in part due to lack of access to evidence-based information on mobility and aging, and knowledge of strategies to maintain or improve mobility with age. The McMaster Optimal Aging Portal (the Portal) was launched in 2014 to increase public access to trustworthy health information. Now the investigators want to know if easy-to-understand evidence-based messages change what people know and do to stay healthy and mobile.

Sequential, explanatory mixed-methods design consisting of a two-armed randomized controlled trial and a qualitative process study to explore quantitative findings in depth.

Consent forms and a baseline survey will be sent to all interested participants. Following baseline data collection, participants will be stratified by previous Portal use, and randomized to the Knowledge Translation (KT) intervention or control group. During the 12-week KT intervention, intervention group participants will have access to the Portal and will receive mobility- focused weekly email alerts including blog posts and evidence summaries relevant to mobility and be invited to follow a Twitter and Facebook feed; a unique hashtag will be created to identify and collate relevant mobility information. Control group participants will be able to access the Portal in a 'self-serve' fashion, but will not receive targeted KT strategies.

Being tested
Tailored Knowledge Translation
Keywords
Mobility, Aging, Knowledge Translation, Physical Activity
Medical subject headings
Mobility Limitation, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tailored Knowledge TranslationOther

    Tailored knowledge translation strategies specific to maintaining and increasing physical mobility with age.

Study groups in NCT02947230
Study groupRoleWhat they receive
Tailored Knowledge TranslationExperimentalDuring the 12-week KT intervention, intervention group participants will have access to the Portal and will receive mobility-focused weekly email alerts including blog posts and evidence summaries relevant to mobility and be invited to follow a Twitter and Facebook feed; a unique hashtag will be created to identify and collate relevant mobility information.
Receives: Other: Tailored Knowledge Translation
Control groupNo interventionParticipants in the control group will have access to the Portal in a 'self-serve' fashion. These participants will be able to browse the Portal, subscribe to email alerts, follow social media, etc. but will not receive the tailored mobility intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Website analytics

    Understanding participant engagement with the Portal and knowledge translation strategies

    Measured: 12 weeks

  2. Email analytics

    Understanding participant engagement with the Portal and knowledge translation strategies

    Measured: 12 weeks

  3. Google analytics

    Understanding participant engagement with the Portal and knowledge translation strategies

    Measured: 12 weeks

Secondary outcomes (5)

  1. Knowledge Questionnaire

    Participants knowledge of mobility recommendations and guidelines

    Measured: 12 weeks, 3 months post-intervention

  2. Beliefs Questionnaire

    Participants beliefs about the importance of maintaining and improving mobility for health

    Measured: 12 weeks, 3 months post-intervention

  3. Intentions Questionnaire

    Participants intentions to engage in lifestyle behaviours related to maintaining or improving mobility

    Measured: 12 weeks, 3 months post-intervention

  4. Rapid Assessment of Physical Activity

    To quantify self-reported physical activity

    Measured: 12 weeks, 3 months post-intervention

  5. Manty Preclinical Mobility Disability Scale

    Mobility limitation

    Measured: 12 weeks, 3 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2016 (estimated)
  2. Study start7 Mar 2017
  3. Primary completion1 Nov 2017
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
535 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02947230
Sponsor's protocol ID
2017-04
Status last verified
Mar 2019
First submitted
21 Oct 2016
Last updated
21 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Neil-Sztramko S, Smith-Turchyn J, Richardson J, Dobbins M. Impact of a Knowledge Translation Intervention on Physical Activity and Mobility in Older Adults (the Move4Age Study): Randomized Controlled Trial. J Med Internet Res. 2020 Feb 11;22(2):e15125. doi: 10.2196/15125.

    PubMed 32044750

  • Neil-Sztramko SE, Smith-Turchyn J, Richardson J, Dobbins M. A Mobility-Focused Knowledge Translation Randomized Controlled Trial to Improve Physical Activity: Process Evaluation of the Move4Age Study. J Med Internet Res. 2019 Jun 20;21(6):e13965. doi: 10.2196/13965.

    PubMed 31223121

Questions about this trial

What is this clinical trial studying?

A study testing Tailored Knowledge Translation in people with Mobility Limitation, run by McMaster University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Website analytics (time frame: 12 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02947230, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2020.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in